XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock, Common
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2022 17,245,954          
Beginning balance at Dec. 31, 2022 $ 0          
Ending balance (in shares) at Mar. 31, 2023 17,245,954          
Ending balance at Mar. 31, 2023 $ 0          
Balance, beginning of period at Dec. 31, 2022 (34,794) $ 0   $ 212,637 $ (247,305) $ (126)
Beginning balance (in shares) at Dec. 31, 2022   8,793,880        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (4,283)       (4,283)  
Other comprehensive income 77         77
Exercise of stock options (in shares)   23,991        
Exercise of stock options 262     262    
Stock-based compensation expense (inclusive of capitalized stock-based compensation) 1,886     1,886    
Release of restricted stock purchase shares from repurchase option (in shares)   25,551        
Release of restricted stock purchase shares from repurchase option 212     212    
Balance, ending of period at Mar. 31, 2023 $ (36,640) $ 0   214,997 (251,588) (49)
Ending balance (in shares) at Mar. 31, 2023   8,843,422        
Beginning balance (in shares) at Dec. 31, 2022 17,245,954          
Beginning balance at Dec. 31, 2022 $ 0          
Ending balance (in shares) at Sep. 30, 2023 17,245,954          
Ending balance at Sep. 30, 2023 $ 0          
Balance, beginning of period at Dec. 31, 2022 (34,794) $ 0   212,637 (247,305) (126)
Beginning balance (in shares) at Dec. 31, 2022   8,793,880        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 19,471          
Other comprehensive income 126          
Balance, ending of period at Sep. 30, 2023 $ 1,273 $ 0   229,107 (227,834) 0
Ending balance (in shares) at Sep. 30, 2023   9,041,759        
Beginning balance (in shares) at Mar. 31, 2023 17,245,954          
Beginning balance at Mar. 31, 2023 $ 0          
Ending balance (in shares) at Jun. 30, 2023 17,245,954          
Ending balance at Jun. 30, 2023 $ 0          
Balance, beginning of period at Mar. 31, 2023 (36,640) $ 0   214,997 (251,588) (49)
Beginning balance (in shares) at Mar. 31, 2023   8,843,422        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 15,341       15,341  
Other comprehensive income 49         49
Exercise of stock options (in shares)   52,228        
Exercise of stock options 409     409    
Stock-based compensation expense (inclusive of capitalized stock-based compensation) 1,898     1,898    
Release of restricted stock purchase shares from repurchase option (in shares)   25,552        
Release of restricted stock purchase shares from repurchase option 212     212    
Balance, ending of period at Jun. 30, 2023 $ (18,731) $ 0   217,516 (236,247) 0
Ending balance (in shares) at Jun. 30, 2023   8,921,202        
Ending balance (in shares) at Sep. 30, 2023 17,245,954          
Ending balance at Sep. 30, 2023 $ 0          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 8,413       8,413  
Other comprehensive income 0          
Exercise of stock options (in shares)   95,006        
Exercise of stock options 483     483    
Stock-based compensation expense (inclusive of capitalized stock-based compensation) 10,896     10,896    
Release of restricted stock purchase shares from repurchase option (in shares)   25,551        
Release of restricted stock purchase shares from repurchase option 212     212    
Balance, ending of period at Sep. 30, 2023 $ 1,273 $ 0   229,107 (227,834) $ 0
Ending balance (in shares) at Sep. 30, 2023   9,041,759        
Beginning balance (in shares) at Dec. 31, 2023 17,245,954          
Beginning balance at Dec. 31, 2023 $ 0          
Ending balance (in shares) at Mar. 31, 2024 17,245,954          
Ending balance at Mar. 31, 2024 $ 0          
Balance, beginning of period at Dec. 31, 2023 $ 27,928 $ 0 [1] $ 0 237,116 (209,188)  
Beginning balance (in shares) at Dec. 31, 2023 9,207,337 9,207,337 [1]        
Beginning balance, treasury stock (in shares) at Dec. 31, 2023 0   0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ 9,297       9,297  
Exercise of stock options (in shares) [1]   187,777        
Exercise of stock options 1,799     1,799    
Stock-based compensation expense (inclusive of capitalized stock-based compensation) 4,950     4,950    
Release of restricted stock purchase shares from repurchase option (in shares) [1]   25,551        
Release of restricted stock purchase shares from repurchase option 212     212    
Other (in shares) [1]   (3,000)        
Other (91)     (91)    
Balance, ending of period at Mar. 31, 2024 $ 44,095 $ 0 [1] $ 0 243,986 (199,891)  
Ending balance (in shares) at Mar. 31, 2024 [1]   9,417,665        
Ending balance, treasury stock (in shares) at Mar. 31, 2024     0      
Beginning balance (in shares) at Dec. 31, 2023 17,245,954          
Beginning balance at Dec. 31, 2023 $ 0          
Ending balance (in shares) at Sep. 30, 2024 0          
Ending balance at Sep. 30, 2024 $ 0          
Balance, beginning of period at Dec. 31, 2023 $ 27,928 $ 0 [1] $ 0 237,116 (209,188)  
Beginning balance (in shares) at Dec. 31, 2023 9,207,337 9,207,337 [1]        
Beginning balance, treasury stock (in shares) at Dec. 31, 2023 0   0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ (7,430)          
Other comprehensive income $ 0          
Exercise of stock options (in shares) 678,582          
Balance, ending of period at Sep. 30, 2024 $ 377,958 $ 0 [1] $ (15,687) 610,263 (216,618)  
Ending balance (in shares) at Sep. 30, 2024 0 30,888,017 [1]        
Ending balance, treasury stock (in shares) at Sep. 30, 2024 (274,902)   (274,902)      
Beginning balance (in shares) at Mar. 31, 2024 17,245,954          
Beginning balance at Mar. 31, 2024 $ 0          
Ending balance (in shares) at Jun. 30, 2024 0          
Ending balance at Jun. 30, 2024 $ 0          
Balance, beginning of period at Mar. 31, 2024 44,095 $ 0 [1] $ 0 243,986 (199,891)  
Beginning balance (in shares) at Mar. 31, 2024 [1]   9,417,665        
Beginning balance, treasury stock (in shares) at Mar. 31, 2024     0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (33,966)       (33,966)  
Exercise of stock options (in shares) [1]   244,112        
Exercise of stock options 2,913     2,913    
Stock-based compensation expense (inclusive of capitalized stock-based compensation) 44,912     44,912    
Release of restricted stock purchase shares from repurchase option (in shares) [1]   25,552        
Release of restricted stock purchase shares from repurchase option 212     212    
Conversion of convertible debt (in shares) [1]   1,177,087        
Conversion of convertible debt $ 103,584     103,584    
Conversion of redeemable convertible preferred stock (in shares) 17,245,954 17,245,954 [1]        
Initial public offering, net of issuance costs (in shares) [1]   2,500,000        
Initial public offering, net of issuance costs of $22.0 million $ 197,952     197,952    
Balance, ending of period at Jun. 30, 2024 $ 359,702 $ 0 [1] $ 0 593,559 (233,857)  
Ending balance (in shares) at Jun. 30, 2024 [1]   30,610,370        
Ending balance, treasury stock (in shares) at Jun. 30, 2024     0      
Ending balance (in shares) at Sep. 30, 2024 0          
Ending balance at Sep. 30, 2024 $ 0          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 17,239       17,239  
Other comprehensive income 0          
Exercise of stock options (in shares) [1]   246,693        
Exercise of stock options 2,946     2,946    
Stock-based compensation expense (inclusive of capitalized stock-based compensation) 13,792     13,792    
Release of restricted stock purchase shares from repurchase option (in shares) [1]   25,551        
Release of restricted stock purchase shares from repurchase option 212     212    
Repurchase of common stock (in shares)     (274,902)      
Repurchase of common stock (15,687)   $ (15,687)      
Issuance of common stock upon settlement of restricted stock units (in shares) [1]   9,474        
Common stock withheld for tax obligation and net settlement (in shares) [1]   (4,071)        
Common stock withheld for tax obligation and net settlement (246)     (246)    
Balance, ending of period at Sep. 30, 2024 $ 377,958 $ 0 [1] $ (15,687) $ 610,263 $ (216,618)  
Ending balance (in shares) at Sep. 30, 2024 0 30,888,017 [1]        
Ending balance, treasury stock (in shares) at Sep. 30, 2024 (274,902)   (274,902)      
[1] Amounts combine the Company’s common stock, Class A common stock, and Class B common stock. See Note 7 - Redeemable Convertible Preferred Stock and Stockholders' Equity for discussion of the establishment of the Company’s two series of common stock and the reclassification of its common stock into Class A common stock in connection with the Company’s initial public offering in April 2024.